These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18802015

  • 1. Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients.
    Stroes ES, Nierman MC, Meulenberg JJ, Franssen R, Twisk J, Henny CP, Maas MM, Zwinderman AH, Ross C, Aronica E, High KA, Levi MM, Hayden MR, Kastelein JJ, Kuivenhoven JA.
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2303-4. PubMed ID: 18802015
    [No Abstract] [Full Text] [Related]

  • 2. Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation.
    Ross CJ, Twisk J, Meulenberg JM, Liu G, van den Oever K, Moraal E, Hermens WT, Rip J, Kastelein JJ, Kuivenhoven JA, Hayden MR.
    Hum Gene Ther; 2004 Sep; 15(9):906-19. PubMed ID: 15353045
    [Abstract] [Full Text] [Related]

  • 3. Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.
    Ferreira V, Twisk J, Kwikkers K, Aronica E, Brisson D, Methot J, Petry H, Gaudet D.
    Hum Gene Ther; 2014 Mar; 25(3):180-8. PubMed ID: 24299335
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy for lipoprotein lipase deficiency: working toward clinical application.
    Rip J, Nierman MC, Sierts JA, Petersen W, Van den Oever K, Van Raalte D, Ross CJ, Hayden MR, Bakker AC, Dijkhuizen P, Hermens WT, Twisk J, Stroes E, Kastelein JJ, Kuivenhoven JA, Meulenberg JM.
    Hum Gene Ther; 2005 Nov; 16(11):1276-86. PubMed ID: 16259561
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy for genetic lipid disorders: lipoprotein lipase deficiency as a paradigm.
    Rader DJ.
    Neth J Med; 2005 Jan; 63(1):2-3. PubMed ID: 15719845
    [No Abstract] [Full Text] [Related]

  • 6. Alipogene tiparvovec, an adeno-associated virus encoding the Ser(447)X variant of the human lipoprotein lipase gene for the treatment of patients with lipoprotein lipase deficiency.
    Burnett JR, Hooper AJ.
    Curr Opin Mol Ther; 2009 Dec; 11(6):681-91. PubMed ID: 20072945
    [Abstract] [Full Text] [Related]

  • 7. Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency.
    Gaudet D, de Wal J, Tremblay K, Déry S, van Deventer S, Freidig A, Brisson D, Méthot J.
    Atheroscler Suppl; 2010 Jun; 11(1):55-60. PubMed ID: 20427244
    [Abstract] [Full Text] [Related]

  • 8. Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
    Nierman MC, Rip J, Twisk J, Meulenberg JJ, Kastelein JJ, Stroes ES, Kuivenhoven JA.
    Neth J Med; 2005 Jan; 63(1):14-9. PubMed ID: 15719847
    [Abstract] [Full Text] [Related]

  • 9. Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency.
    Haddley K.
    Drugs Today (Barc); 2013 Mar; 49(3):161-70. PubMed ID: 23527320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients.
    Carpentier AC, Frisch F, Labbé SM, Gagnon R, de Wal J, Greentree S, Petry H, Twisk J, Brisson D, Gaudet D.
    J Clin Endocrinol Metab; 2012 May; 97(5):1635-44. PubMed ID: 22438229
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipoprotein lipase deficiency in an infant.
    Nampoothiri S, Radhakrishnan N, Schwentek A, Hoffmann MM.
    Indian Pediatr; 2011 Oct; 48(10):805-6. PubMed ID: 22080683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation.
    Ross CJ, Twisk J, Bakker AC, Miao F, Verbart D, Rip J, Godbey T, Dijkhuizen P, Hermens WT, Kastelein JJ, Kuivenhoven JA, Meulenberg JM, Hayden MR.
    Hum Gene Ther; 2006 May; 17(5):487-99. PubMed ID: 16716106
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adeno-associated virus LPL(S447X) gene therapy in LDL receptor knockout mice.
    Rip J, Sierts JA, Vaessen SF, Kastelein JJ, Twisk J, Kuivenhoven JA.
    Atherosclerosis; 2007 Sep; 194(1):55-61. PubMed ID: 17087965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.